Diabetes Drug Market Size

1
Diabetes Drug Market

2
Report Description and Highlights
Analyst View Global diabetes drug market is
expected to surpass US 76 Billion by the end of
year 2024. Rising global diabetes prevalence like
Type 1 diabetes and Type 2 diabetes is the major
reason for growth of diabetes drug market. Type 2
diabetes is on the rise globally due to growth in
obesity trends, sedentary lifestyle and lack of
physical activity. Type1 diabetes patient
requires less amount diabetes drug, whereas Type
2 diabetes patient are massive consumer of
diabetes drug. Renub Research report titled
Diabetes Drug Market, Oral (DPP IV Inhibitor,
SGLT-2, Alpha Glucosidase Inhibitor, Biguanide)
Injection (Glucagon-like peptide (GLP) 1 agonist,
Amylin Receptor Agonist), Insulin (Rapid Acting
Insulin, Long Acting Insulin, Premixed Insulin),
Regions (United States, Europe, Japan, China,
India, Brazil) Companies provides a complete
analysis of Diabetes Drug Market. Read more
here https//www.renub.com/diabetes-drug-market-
p.php


3
(DPP) IV Inhibitor Segment has the largest Market
in Global Diabetes Drug Market

• According to Renub Research this report provides
  in-depth analysis of diabetes drug market form
  multiple perspectives. Here the global diabetes
  drug market has been categorized into 3 segments
  Oral Diabetes Drug Market, Injectable Diabetes
  Drug Market and Insulin.
• Oral Diabetes Drug Market is further sub-divided
  into 5 categories by drug class- (DPP) IV
  Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor,
  Biguanide and Other Oral Drug market.
• Injectable Diabetes Drug Market has been further
  classified into 2 parts - Glucagon-like peptide
  (GLP) 1 agonist and Amylin receptor agonist
  market.
• Insulin Market has been further categorized into
  4 parts - Rapid Acting Insulin market, Long
  Acting Insulin market, Premixed Insulin market
  and Other Insulin market.

4
Global Forecast for Diabetes Drug Market Share
Global Forecast for Diabetes Drug Market Share by
Oral Drug (), 2018 - 2024

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
5
United States dominates the Global diabetes drug
Market
The regions covered in the report for of type 1
diabetes drug market are United States, European
Union (France, Germany, Italy, Spain and United
Kingdom), Japan and Canada.  The regions covered
for type 2 diabetes drug market - are United
States, European Union (France, Germany, Italy,
Spain and United Kingdom), Japan, China, India
and Brazil. In addition, we have also covered
diabetes population of each of these covered
regions along with Type 1 and Type 2 diabetes
populations. Novo Nordisk is the Largest Player
in Global Diabetes Drug Market In this report,
published by Renub Research a comprehensive
assessment of global diabetes drug revenue by
five major key players is covered. The key
players covered in the report are Novo Nordisk,
Merck Co, Eli Lilly, AstraZeneca, Johnson
Johnson and Boehringer Ingelheim. Want more
Information about this market? Request a free
sample copy https//www.renub.com/contactus.php

6
Global Forecast for Diabetes Drug Market Share
Global Forecast for Diabetes Drug Market Share by
Regions - Type 2 (), 2018 - 2024


Source Renub Research Analysis Note These are
dummy figures actual data given in the report
Source Renub Research Analysis Note These are
dummy figures actual data given in the report
7
Key Players covered in this report
Key Players Analysis 1.    Novo Nordisk2.  
 Merck Co3.    Eli Lilly4.  
 AstraZeneca5.    Johnson Johnson6.  
 Boehringer Ingelheim Browse Related Report
Global CGM Market Insulin Pump
Market Contact Us Rajat Gupta Tel
1-678-302-0700 Email info_at_renub.com